Indeed, uPAR transcript variants have been previously reported in various cell types, including PMN, PBMC, THP1 leukemia cells [19, 44]; further, uPAR variant del4/5 mRNA (lacking exons 4 and 5) has been proposed as a novel prognostic marker in breast cancer [45–46]. Here, PLAUR is linked to breast cancer.